These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9345421)

  • 1. Inhibitors of tumor necrosis factor-alpha: promising agents for the treatment of multiple sclerosis?
    Hohlfeld R
    Mult Scler; 1996 Jul; 1(6):376-8. PubMed ID: 9345421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transmembrane tumour necrosis factor is neuroprotective and regulates experimental autoimmune encephalomyelitis via neuronal nuclear factor-kappaB.
    Taoufik E; Tseveleki V; Chu SY; Tselios T; Karin M; Lassmann H; Szymkowski DE; Probert L
    Brain; 2011 Sep; 134(Pt 9):2722-35. PubMed ID: 21908876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple sclerosis: TNF revisited, with promise.
    Raine CS
    Nat Med; 1995 Mar; 1(3):211-4. PubMed ID: 7585035
    [No Abstract]   [Full Text] [Related]  

  • 4. Multiple sclerosis and related disorders: evolving pathophysiologic insights.
    Bar-Or A
    Lancet Neurol; 2016 Jan; 15(1):9-11. PubMed ID: 26700897
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic effects of dasatinib in mouse model of multiple sclerosis.
    Azizi G; Goudarzvand M; Afraei S; Sedaghat R; Mirshafiey A
    Immunopharmacol Immunotoxicol; 2015 Jun; 37(3):287-94. PubMed ID: 25975582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokines in the pathogenesis and therapy of autoimmune encephalomyelitis and multiple sclerosis.
    Willenborg DO; Staykova MA
    Adv Exp Med Biol; 2003; 520():96-119. PubMed ID: 12613575
    [No Abstract]   [Full Text] [Related]  

  • 7. Hypothesis: a role for tumor necrosis factor in immune-mediated demyelination and its relevance to multiple sclerosis.
    Brosnan CF; Selmaj K; Raine CS
    J Neuroimmunol; 1988 Apr; 18(1):87-94. PubMed ID: 3257971
    [No Abstract]   [Full Text] [Related]  

  • 8. Quinpramine: revival of old anti-inflammatory principles in multiple sclerosis?
    Haghikia A; Gold R
    Exp Neurol; 2009 Jun; 217(2):240-1. PubMed ID: 19361499
    [No Abstract]   [Full Text] [Related]  

  • 9. Apolipoprotein E-derived peptides ameliorate clinical disability and inflammatory infiltrates into the spinal cord in a murine model of multiple sclerosis.
    Li FQ; Sempowski GD; McKenna SE; Laskowitz DT; Colton CA; Vitek MP
    J Pharmacol Exp Ther; 2006 Sep; 318(3):956-65. PubMed ID: 16740622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitoxantrone in multiple sclerosis.
    Neuhaus O; Kieseier BC; Hartung HP
    Adv Neurol; 2006; 98():293-302. PubMed ID: 16400840
    [No Abstract]   [Full Text] [Related]  

  • 11. Ulinastatin attenuates experimental autoimmune encephalomyelitis by enhancing anti-inflammatory responses.
    Feng M; Shu Y; Yang Y; Zheng X; Li R; Wang Y; Dai Y; Qiu W; Lu Z; Hu X
    Neurochem Int; 2014 Jan; 64():64-72. PubMed ID: 24274996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local delivery of TNF by retrovirus-transduced T lymphocytes exacerbates experimental autoimmune encephalomyelitis.
    Dal Canto RA; Shaw MK; Nolan GP; Steinman L; Fathman CG
    Clin Immunol; 1999 Jan; 90(1):10-4. PubMed ID: 9884347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with soluble tumor necrosis factor receptor (sTNFR):Fc/p80 fusion protein ameliorates relapsing-remitting experimental autoimmune encephalomyelitis and decreases chemokine expression.
    Glabinski AR; Bielecki B; Kawczak JA; Tuohy VK; Selmaj K; Ransohoff RM
    Autoimmunity; 2004; 37(6-7):465-71. PubMed ID: 15621573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined therapy with methylprednisolone and erythropoietin in a model of multiple sclerosis.
    Diem R; Sättler MB; Merkler D; Demmer I; Maier K; Stadelmann C; Ehrenreich H; Bähr M
    Brain; 2005 Feb; 128(Pt 2):375-85. PubMed ID: 15601662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Future neuroprotective strategies.
    Sättler MB; Bähr M
    Exp Neurol; 2010 Sep; 225(1):40-7. PubMed ID: 19716365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for VAV1 in experimental autoimmune encephalomyelitis and multiple sclerosis.
    Jagodic M; Colacios C; Nohra R; Dejean AS; Beyeen AD; Khademi M; Casemayou A; Lamouroux L; Duthoit C; Papapietro O; Sjöholm L; Bernard I; Lagrange D; Dahlman I; Lundmark F; Oturai AB; Soendergaard HB; Kemppinen A; Saarela J; Tienari PJ; Harbo HF; Spurkland A; Ramagopalan SV; Sadovnick DA; Ebers GC; Seddighzadeh M; Klareskog L; Alfredsson L; Padyukov L; Hillert J; Clanet M; Edan G; Fontaine B; Fournié GJ; Kockum I; Saoudi A; Olsson T
    Sci Transl Med; 2009 Dec; 1(10):10ra21. PubMed ID: 20368159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic impact of orally administered cannabinoid oil extracts in an experimental autoimmune encephalomyelitis animal model of multiple sclerosis.
    Zhou T; Ahmad TK; Alrushaid S; Pozdirca M; Ethans K; Intrater H; Le T; Burczynski F; Kong J; Namaka M
    Biochem Biophys Res Commun; 2019 Aug; 516(2):373-380. PubMed ID: 31213295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and experimental study on multiple sclerosis with bushen gusui tablet].
    Liu XY; Sun Y
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2001 Jan; 21(1):10-4. PubMed ID: 12577368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroinflammatory TNFα Impairs Memory via Astrocyte Signaling.
    Habbas S; Santello M; Becker D; Stubbe H; Zappia G; Liaudet N; Klaus FR; Kollias G; Fontana A; Pryce CR; Suter T; Volterra A
    Cell; 2015 Dec; 163(7):1730-41. PubMed ID: 26686654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglobulins treatment in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Achiron A; Miron S
    Mult Scler; 2000 Oct; 6 Suppl 2():S6-8; discussion S33. PubMed ID: 11188777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.